Posted in | News | Optics and Photonics

LightPath Technologies to Unveil New Products at Photonics West 2013 Exhibition

LightPath Technologies, Inc., a global manufacturer, distributor and integrator of patented optical components and high-level assemblies, today announced it will exhibit at the Photonics West 2013 Exhibition. The show takes place February 5-7 at the Moscone Center in San Francisco, CA.

LightPath invites you to stop by and visit Booth #2211 and be among the first to see the new products that it will launch, including:

  • Green lenses: Molded glass aspheric optics optimized to provide high transmission and improved performance for green diode lasers
  • Connectorized collimators: Product line expanded to include 405nm and 633nm wavelengths, new choices for a variety of beam sizes, and a more rugged, improved glass optic
  • Long Wave InfraRed (LWIR) collimating optics: New long wavelength collimating lenses designed to collimate quantum cascade lasers

Representing LightPath will be Jim Gaynor , the company's CEO, who commented, "We are excited to showcase our progress in the infrared and other fast-growing optics markets at this critical industry event. Our green laser lens technology is among the industry's best, and we look forward to the opportunity to demonstrate this technology to OEMs, partners, and prospects and continue to increase the market's awareness and acceptance of our state-of-the-art products and technology."

Photonics West, attracts 20,000 attendees each year, and is considered among the elite events for the lasers and photonics industry. With more than 1,200 OEMs and vendors as exhibitors in 2012, and more expected in 2013, Photonics West will feature the latest products, tools, and applications in the industry.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.